Loading clinical trials...
Loading clinical trials...
Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
PRIMARY OBJECTIVES: I. Conduct a randomized, controlled trial evaluating the efficacy of a conversation tool on patient-centered health and decision-making outcomes among patients making lung cancer treatment decisions. A subset of participants from control and intervention groups will also have their clinic conversations with providers recorded II. Conduct in-depth, semi-structured qualitative audio or video recorded interviews among a subset of Aim 1 participants. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients review decision aid. GROUP II: Patients receive standard of care. After completion of study intervention, patients are followed up at 2 weeks, 3 months, and 6 months.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
Hillsboro Medical Center
Hillsboro, Oregon, United States
Adventist Health Portland
Portland, Oregon, United States
OHSU Knight Cancer Institute
Portland, Oregon, United States
Portland VA Medical Center
Portland, Oregon, United States
Start Date
October 31, 2022
Primary Completion Date
September 30, 2026
Completion Date
December 31, 2027
Last Updated
April 9, 2025
300
ESTIMATED participants
Best Practice
OTHER
Health Promotion and Education
OTHER
Questionnaire Administration
OTHER
Lead Sponsor
OHSU Knight Cancer Institute
Collaborators
NCT04585750
NCT07219251
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions